share_log

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Officer Hickey Benjamin

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities

施貴寶 | 4：持股變動聲明
SEC announcement ·  03/12 17:49
Moomoo AI 已提取核心訊息
On March 10, 2024, Benjamin Hickey, President of RayzeBio Org., engaged in a transaction involving the common stock of Bristol-Myers Squibb (BMY). Following the transaction, Hickey directly holds 780 shares of the company's common stock, each with a par value of $0.10. Additionally, there are 91 shares held indirectly by Hickey's spouse, bringing the total beneficial ownership to 871 shares. The nature of the indirect ownership is specified as being through the spouse. This transaction reflects changes in the holdings of a key individual within the company, which may be of interest to current and potential investors.
On March 10, 2024, Benjamin Hickey, President of RayzeBio Org., engaged in a transaction involving the common stock of Bristol-Myers Squibb (BMY). Following the transaction, Hickey directly holds 780 shares of the company's common stock, each with a par value of $0.10. Additionally, there are 91 shares held indirectly by Hickey's spouse, bringing the total beneficial ownership to 871 shares. The nature of the indirect ownership is specified as being through the spouse. This transaction reflects changes in the holdings of a key individual within the company, which may be of interest to current and potential investors.
2024年3月10日，RayzeBio Org. 總裁本傑明·希基進行了一項涉及百時美施貴寶（BMY）普通股的交易。交易完成後，Hickey直接持有該公司780股普通股，每股面值爲0.10美元。此外，Hickey的配偶間接持有91股股份，使實際所有權總數達到871股。間接所有權的性質被規定爲通過配偶擁有。該交易反映了公司內部關鍵個人的持股變化，當前和潛在投資者可能會對此感興趣。
2024年3月10日，RayzeBio Org. 總裁本傑明·希基進行了一項涉及百時美施貴寶（BMY）普通股的交易。交易完成後，Hickey直接持有該公司780股普通股，每股面值爲0.10美元。此外，Hickey的配偶間接持有91股股份，使實際所有權總數達到871股。間接所有權的性質被規定爲通過配偶擁有。該交易反映了公司內部關鍵個人的持股變化，當前和潛在投資者可能會對此感興趣。
有用
沒用

該公告為獨立文件：

獨立文件1

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息